Stroke: Covidien wins Canadian OK for its Solitaire revascularization device

December 13, 2012 by MassDevice staff

Health Canada approves Covidien's to Solitaire revascularization device for restoring blood flow to the brain in patients with acute ischemic stroke.

Covidien logo

Medtech giant Covidien (NYSE:COV) won Health Canada approval for its Solitaire FR revascularization device, intended to remove blood clots and restore blood flow in the brains of patients suffering acute ischemic stroke.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp